-
Featured
Mortality in COVID-19 Does Not Appear to Be Driven by Liver Failure
Massachusetts General Hospital researchers report that elevated liver function tests are common in COVID-19, but severe liver injury is rare, and no case of liver failure or dysfunction leading to death has been attributed directly to COVID-19.
-
Featured
Patients with Decompensated Cirrhosis Need Earlier End-of-Life Planning
Regardless of transplant candidacy, patients with decompensated cirrhosis spend a substantial portion of their last 90 days of life in the hospital, are likely to receive intensive interventions at the end of life and tend to be referred late, if at all, to palliative or hospice care.
-
Featured
Early Transplantation for Alcohol-associated Hepatitis Improves Survival
According to a mathematical model, offering liver transplantation with no minimum period of sobriety before surgery (i.e., early liver transplantation) for severe alcohol-associated hepatitis provides a fourfold increase in life expectancy compared with requiring a six-month period of sobriety before listing. having characteristics similar to patients in ACCELERATE-AH trial.
-
Review: Liver Disease in HCV/HIV Coinfection
Andre J. Jeyarajan and Raymond T. Chung, MD, of the Division of Gastroenterology, explain why clearance of the hepatitis C virus is insufficient to prevent further liver damage and progression in HCV/HIV coinfected patients.
-
Screening for Early Detection of Malignancies of the GI Tract
Daniel Chung, MD, is a gastroenterologist and medical co-director of the Center for Cancer Risk Analysis in the Mass General Cancer Center. In this video, he discusses his work on screening and early detection of malignancies of the GI tract, and how that work will improve detection rates during colonoscopy.
-
Cardiovascular Disease Independently Associated with NAFLD in People with HIV
Cardiovascular disease, higher body mass index and CD4 count <200 cells/mm3 were significantly associated with nonalcoholic fatty liver disease among adults with HIV, even after adjustment for traditional cardiovascular disease risk factors.
Liver contributors
-
Emily D. Bethea, MD
Associate Clinical Director of Liver Transplantation, Massachusetts General Hospital
-
Jagpreet Chhatwal, PhD
Associate Director, Institute for Technology Assessment, Assistant Professor, Harvard Medical School
Recent Article
County-level COVID-19 Data Confirms Effectiveness of Workplace Closure
-
Kathleen E. Corey, MD, MPH
Director, Fatty Liver Clinic, Mass General Gastrointestinal Unit, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Cardiovascular Disease Independently Associated with NAFLD in People with HIV
-
Raymond T. Chung, MD
Vice Chief, Gastrointestinal Division, Director of Hepatology and Liver Center, Medical Director, Liver Transplant Program
Recent Article
Review: Liver Disease in HCV/HIV Coinfection
-
Russell P. Goodman, MD, DPhil
Hepatologist, Division of Gastroenterology, Massachusetts General Hospital, Instructor in Medicine, Harvard Medical School
Recent Article
Imbalance of Electrons in the Liver May Be A Risk Factor for Many Common Diseases
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.
